课题基金 / 基金详情

Study of immunologic evasion of human papllomavirus (HPV) Against host immuno-ersponse in patient with cervical cancer

Study of immunologic evasion of human papllomavirus (HPV) Against host immuno-ersponse in patient with cervical cancer
宫颈癌患者人乳头瘤病毒(HPV)抵抗宿主免疫反应的免疫逃避研究
批准号:
10671526
负责人:
SASAGAWA Toshiyuki
金额:
$1.73万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

SASAGAWA Toshiyuki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have recently established the system to detect DNA of most mucosal HPV types using PCR method, which is called LCR-E7 PCR method. Using this method, we tested the prevalence of HPV infection in clinical samples. More than 17 HPV types were identified in normal, condyloma and lower-grade squamous intraepithelial lesions (LSIL). Higher incidence of infection with multiple HPV types was observed in these benign lesions than in the malignant lesions such as high-grade squamous intraepithelial lesions (HSIL) and invasive cervical (ICCA). HPV 16, 18, 31, 33, 51, 52, 56, and 58 were detected as a single infection in HSIL and ICCA, suggesting these are high-risk types for cancer. HPV51, 52 and 58 were more prevalent, whereas HPV18, 33 and 56 were less prevalent in Japanese ICCA than that in the USA.We investigated an association between HLA class II types and susceptibility for cervical cancer or the high-risk HPV infection. Women with HLA DR3, 4 were more susceptible to the high-risk HPV infection, and women with HLA DR2, 3, 4, 5 or with DR2-DQw1, DR3-DQw2, DR5-DQw3 haplotypes were susceptible to cervical cancer. Interestingly, women with DR2, 3, 4, 5 showed higher titers of anti-HPV 16 antibodies that in women with the other HLA types. This suggests that up-regulation of Th2 type immuno-response inducing strong humoral immuno-response may occur in these women with DR2, 3, 4, 5. We surmised that those women may have weaker Th1 response that make susceptible to HPV infection and cervical cancer. Immunohistochemical analysis showed no specific expression patterns of both Th1 and Th2-related cytokines in some tissue samples of cervical cancer. It may be important to study much more samples for such cytokine responses to conduct certain conclusions.
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
T. Sasagawa: "FHIT Abnormalities and HPV E6/E7 mRNA Expression in the development of cervical cancer"Cancer. 85. 2001-2010 (1999)
T. Sasakawa:“宫颈癌发展过程中的 FHIT 异常和 HPV E6/E7 mRNA 表达”癌症。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T. Sasagawa: "Epstein-Barr virus (EBV) genes expression in cervical intraepithelial neoplasia and invasive cervical cancer : A comparative study with human papillomavirus (HPV) infection"Human Pathology. (印刷中). (2000)
T.笹川:“宫颈上皮内瘤变和浸润性宫颈癌中的 Epstein-Barr 病毒 (EBV) 基因表达:与人乳头瘤病毒 (HPV) 感染的比较研究”人类病理学 (2000 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T. Noda, T. Sasagawa et al.: "Detection of human papillomavirus (HPV) DNA in archival speciments of benign prostatic hyperplasia and prostatic cancer using a highly sensitive-nested PCR method."Urological Res.. 26. 165-169 (1998)
T. Noda、T. Sasakawa 等人:“使用高度灵敏的巢式 PCR 方法检测良性前列腺增生和前列腺癌档案样本中的人乳头瘤病毒 (HPV) DNA。”泌尿学研究 26. 165-169 (
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
笹川寿之、瀬川智也、井上正樹: "パピローマウイルスの診断法" 臨床検査. (近日出版). (1999)
Toshiyuki Sasakawa、Tomoya Sekawa、Masaki Inoue:“乳头瘤病毒的诊断方法”临床检查(即将出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
27
    Expression and immunoreactivity of high-risk human papillomavirus E4 prtein
    • 批准号:
      18591827
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.51万
    • 财政年份:
      2006
    • 负责人:
      SASAGAWA Toshiyuki
    • 依托单位:
    Prophylactic and therapeutic HPV16 vaccine using yeast expressing chimeric L1 and E7 protein.
    • 批准号:
      15591735
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2003
    • 负责人:
      SASAGAWA Toshiyuki
    • 依托单位:
    ORALLY ADMINISTERED HPV 16 VACCINE STIMULATING GUT-ASSOCIATED LYMPHOID TISSUES
    • 批准号:
      13671701
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $0.64万
    • 财政年份:
      2001
    • 负责人:
      SASAGAWA Toshiyuki
    • 依托单位:
    The development of serological test detecting antibodies against oncogenic human papillomaviruses by ELISA
    • 批准号:
      08671877
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.54万
    • 财政年份:
      1996
    • 负责人:
      SASAGAWA Toshiyuki
    • 依托单位:
    海外基金